Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.79% 1D
NAV on
Fund Summary
Ionic AI
Loading...
Fund Overview
- Rating
3 - Minimum Investment₹100
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹172 Cr
- Created on1 Oct 2020
Fund Ranking
#16
/ 14 in Sectoral-Pharma
Risk Level
Very High
Returns
Trailing Return
Rolling Return
- 6 Month2.6%
- 1 Year14.6%
- 3 Year (CAGR)19.5%
- All Time (CAGR)14.6%
Category Return
- 6 Month4.9%
- 1 Year10.6%
- 3 Year (CAGR)23.0%
- All Time (CAGR)-
Asset Allocation
- Equity99.7%
- Debt0.3%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise5.65%
- Aurobindo Pharma2.49%
- Cipla5.08%
- Dr. Reddy's Laboratories4.92%
- Ipca Laboratories1.46%
Fund Information
- Expense Ratio1.86%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Managed By
Bhavesh Jain
Oct 2021 - Present
Amit Vora
Feb 2021 - Present
Manasi Jalgaonkar
April 2026 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.09 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 12.53 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 1.03 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.66